Latka logo
Delfi Diagnostics logo

Delfi Diagnosticsrevenue & acquisition

Generative AI SoftwareBaltimore, Maryland

Delfi Diagnostics was acquired.

DELFI (DNA evaluation of fragments for early interception) employs artificial intelligence and whole-genome sequencing to sensitively and accurately identify distinctive patterns of DNA fragmentation in the blood of patients with cancer.

delfidiagnostics.comLinkedInUpdated Oct 5, 2026
Annual revenue
$51.8M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
250
Dec 2023EST

Delfi Diagnostics revenue

Delfi Diagnostics has not published its revenue. Growjo puts it at about $51.8M a year (December 2023).

$0
$20M
$40M
$51.8M
2023
ReportedEstimateEvery reading has its own bar
As ofRevenueSource
Dec 2023$51.8MESTGrowjo estimate

Who owns Delfi Diagnostics

Another company owns Delfi Diagnostics. The date and price of the deal are not on record.

Delfi Diagnostics CEO, founders & employees

Susan Tousi founded Delfi Diagnostics and led it as CEO. Delfi Diagnostics had 250 employees (December 2023, Growjo estimate).

0
100
200
220
250
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 2023250ESTGrowjo estimate
Dec 2022220ESTGrowjo estimate

Delfi Diagnostics FAQ

What was Delfi Diagnostics' revenue?

Growjo estimates Delfi Diagnostics' revenue at about $51.8M a year (December 2023). The company hasn't published its own figure.

How many employees does Delfi Diagnostics have?

Growjo estimates Delfi Diagnostics' headcount at about 250 (December 2023).

Who founded Delfi Diagnostics?

Susan Tousi founded Delfi Diagnostics.

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun Delfi Diagnostics? Join the podcast